CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2024

Nov 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2024-11-13

Reporting Person: MCENANY PATRICK J (Director, Chairman of Board of Directors)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-13	Common stock, par value $0.001 per share	M	92500	$3.54	Acquired	4570669	Direct
2024-11-13	Common stock, par value $0.001 per share	S	92500	$22.978	Disposed	4478169	Direct
2024-11-14	Common stock, par value $0.001 per share	M	44655	$3.54	Acquired	4522824	Direct
2024-11-14	Common stock, par value $0.001 per share	S	44655	$21.752	Disposed	4478169	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-13	Options to purchase common stock	$3.54	M	92500	Disposed	2025-05-29	Common Stock (92500)	Direct
2024-11-14	Options to purchase common stock	$3.54	M	44655	Disposed	2025-05-29	Common Stock (44655)	Direct

Footnotes

F1: Shares were sold for personal reasons, including paying federal income taxes and diversifying the Reporting Person's portfolio. Shares were not sold as a result of any disagreement with the Company. Mr. McEnany remains the non-executive chairman of the Company's Board of Directors and the Company's largest individual, non-institutional shareholder.

F2: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $22.82 to $23.13 per share.

F3: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $21.52 to $22.20 per share.

F4: Options vested in three equal tranches on May 29, 2019, 2020 and 2021.